Global Viral Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Viral Gene Therapy Industry Forecast” looks at past sales and reviews total world Viral Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Gene Therapy sales for 2023 through 2029. With Viral Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Viral Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Gene Therapy.
The global Viral Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Viral Gene Therapy players cover Lonza, Biogen, Catalent, Gilead Sciences, Sarepta Therapeutics, Novartis, Amgen, Ionis Pharmaceuticals and Spark Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Viral Gene Therapy Industry Forecast” looks at past sales and reviews total world Viral Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Gene Therapy sales for 2023 through 2029. With Viral Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Viral Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Gene Therapy.
The global Viral Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Viral Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Viral Gene Therapy players cover Lonza, Biogen, Catalent, Gilead Sciences, Sarepta Therapeutics, Novartis, Amgen, Ionis Pharmaceuticals and Spark Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Integrating Viral Vectors
- Non-Integrating Viral Vectors
- Metabolic Diseases
- Cardiovascular Diseases
- Muscular Diseases
- Hematologic Diseases
- Ophthalmologic Diseases
- Infectious Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Biogen
- Catalent
- Gilead Sciences
- Sarepta Therapeutics
- Novartis
- Amgen
- Ionis Pharmaceuticals
- Spark Therapeutics
- Shanghai Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Gene Therapy Market Size 2018-2029
2.1.2 Viral Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Viral Gene Therapy Segment by Type
2.2.1 Integrating Viral Vectors
2.2.2 Non-Integrating Viral Vectors
2.3 Viral Gene Therapy Market Size by Type
2.3.1 Viral Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Viral Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Viral Gene Therapy Segment by Application
2.4.1 Metabolic Diseases
2.4.2 Cardiovascular Diseases
2.4.3 Muscular Diseases
2.4.4 Hematologic Diseases
2.4.5 Ophthalmologic Diseases
2.4.6 Infectious Diseases
2.4.7 Others
2.5 Viral Gene Therapy Market Size by Application
2.5.1 Viral Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Viral Gene Therapy Market Size Market Share by Application (2018-2023)
3 VIRAL GENE THERAPY MARKET SIZE BY PLAYER
3.1 Viral Gene Therapy Market Size Market Share by Players
3.1.1 Global Viral Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Viral Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Viral Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL GENE THERAPY BY REGIONS
4.1 Viral Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Viral Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Viral Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Viral Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Viral Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Viral Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Viral Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Viral Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Viral Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Viral Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Gene Therapy by Country (2018-2023)
7.2 Europe Viral Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Viral Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Viral Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Viral Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL GENE THERAPY MARKET FORECAST
10.1 Global Viral Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Viral Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Viral Gene Therapy Forecast
10.1.3 APAC Viral Gene Therapy Forecast
10.1.4 Europe Viral Gene Therapy Forecast
10.1.5 Middle East & Africa Viral Gene Therapy Forecast
10.2 Americas Viral Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Viral Gene Therapy Market Forecast
10.2.2 Canada Viral Gene Therapy Market Forecast
10.2.3 Mexico Viral Gene Therapy Market Forecast
10.2.4 Brazil Viral Gene Therapy Market Forecast
10.3 APAC Viral Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Viral Gene Therapy Market Forecast
10.3.2 Japan Viral Gene Therapy Market Forecast
10.3.3 Korea Viral Gene Therapy Market Forecast
10.3.4 Southeast Asia Viral Gene Therapy Market Forecast
10.3.5 India Viral Gene Therapy Market Forecast
10.3.6 Australia Viral Gene Therapy Market Forecast
10.4 Europe Viral Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Viral Gene Therapy Market Forecast
10.4.2 France Viral Gene Therapy Market Forecast
10.4.3 UK Viral Gene Therapy Market Forecast
10.4.4 Italy Viral Gene Therapy Market Forecast
10.4.5 Russia Viral Gene Therapy Market Forecast
10.5 Middle East & Africa Viral Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Viral Gene Therapy Market Forecast
10.5.2 South Africa Viral Gene Therapy Market Forecast
10.5.3 Israel Viral Gene Therapy Market Forecast
10.5.4 Turkey Viral Gene Therapy Market Forecast
10.5.5 GCC Countries Viral Gene Therapy Market Forecast
10.6 Global Viral Gene Therapy Forecast by Type (2024-2029)
10.7 Global Viral Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Viral Gene Therapy Product Offered
11.1.3 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Viral Gene Therapy Product Offered
11.2.3 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Viral Gene Therapy Product Offered
11.3.3 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Viral Gene Therapy Product Offered
11.4.3 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Information
11.5.2 Sarepta Therapeutics Viral Gene Therapy Product Offered
11.5.3 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sarepta Therapeutics Main Business Overview
11.5.5 Sarepta Therapeutics Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Viral Gene Therapy Product Offered
11.6.3 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Viral Gene Therapy Product Offered
11.7.3 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Ionis Pharmaceuticals
11.8.1 Ionis Pharmaceuticals Company Information
11.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Offered
11.8.3 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Ionis Pharmaceuticals Main Business Overview
11.8.5 Ionis Pharmaceuticals Latest Developments
11.9 Spark Therapeutics
11.9.1 Spark Therapeutics Company Information
11.9.2 Spark Therapeutics Viral Gene Therapy Product Offered
11.9.3 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spark Therapeutics Main Business Overview
11.9.5 Spark Therapeutics Latest Developments
11.10 Shanghai Sunway Biotech
11.10.1 Shanghai Sunway Biotech Company Information
11.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Offered
11.10.3 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Shanghai Sunway Biotech Main Business Overview
11.10.5 Shanghai Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Viral Gene Therapy Product Offered
11.11.3 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Viral Gene Therapy Product Offered
11.12.3 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Viral Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Gene Therapy Market Size 2018-2029
2.1.2 Viral Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Viral Gene Therapy Segment by Type
2.2.1 Integrating Viral Vectors
2.2.2 Non-Integrating Viral Vectors
2.3 Viral Gene Therapy Market Size by Type
2.3.1 Viral Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Viral Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Viral Gene Therapy Segment by Application
2.4.1 Metabolic Diseases
2.4.2 Cardiovascular Diseases
2.4.3 Muscular Diseases
2.4.4 Hematologic Diseases
2.4.5 Ophthalmologic Diseases
2.4.6 Infectious Diseases
2.4.7 Others
2.5 Viral Gene Therapy Market Size by Application
2.5.1 Viral Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Viral Gene Therapy Market Size Market Share by Application (2018-2023)
3 VIRAL GENE THERAPY MARKET SIZE BY PLAYER
3.1 Viral Gene Therapy Market Size Market Share by Players
3.1.1 Global Viral Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Viral Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Viral Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VIRAL GENE THERAPY BY REGIONS
4.1 Viral Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Viral Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Viral Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Viral Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Viral Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Viral Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Viral Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Viral Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Viral Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Viral Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Viral Gene Therapy by Country (2018-2023)
7.2 Europe Viral Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Viral Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Viral Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Viral Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VIRAL GENE THERAPY MARKET FORECAST
10.1 Global Viral Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Viral Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Viral Gene Therapy Forecast
10.1.3 APAC Viral Gene Therapy Forecast
10.1.4 Europe Viral Gene Therapy Forecast
10.1.5 Middle East & Africa Viral Gene Therapy Forecast
10.2 Americas Viral Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Viral Gene Therapy Market Forecast
10.2.2 Canada Viral Gene Therapy Market Forecast
10.2.3 Mexico Viral Gene Therapy Market Forecast
10.2.4 Brazil Viral Gene Therapy Market Forecast
10.3 APAC Viral Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Viral Gene Therapy Market Forecast
10.3.2 Japan Viral Gene Therapy Market Forecast
10.3.3 Korea Viral Gene Therapy Market Forecast
10.3.4 Southeast Asia Viral Gene Therapy Market Forecast
10.3.5 India Viral Gene Therapy Market Forecast
10.3.6 Australia Viral Gene Therapy Market Forecast
10.4 Europe Viral Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Viral Gene Therapy Market Forecast
10.4.2 France Viral Gene Therapy Market Forecast
10.4.3 UK Viral Gene Therapy Market Forecast
10.4.4 Italy Viral Gene Therapy Market Forecast
10.4.5 Russia Viral Gene Therapy Market Forecast
10.5 Middle East & Africa Viral Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Viral Gene Therapy Market Forecast
10.5.2 South Africa Viral Gene Therapy Market Forecast
10.5.3 Israel Viral Gene Therapy Market Forecast
10.5.4 Turkey Viral Gene Therapy Market Forecast
10.5.5 GCC Countries Viral Gene Therapy Market Forecast
10.6 Global Viral Gene Therapy Forecast by Type (2024-2029)
10.7 Global Viral Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Viral Gene Therapy Product Offered
11.1.3 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Viral Gene Therapy Product Offered
11.2.3 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Viral Gene Therapy Product Offered
11.3.3 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Viral Gene Therapy Product Offered
11.4.3 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Information
11.5.2 Sarepta Therapeutics Viral Gene Therapy Product Offered
11.5.3 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sarepta Therapeutics Main Business Overview
11.5.5 Sarepta Therapeutics Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Viral Gene Therapy Product Offered
11.6.3 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Viral Gene Therapy Product Offered
11.7.3 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Ionis Pharmaceuticals
11.8.1 Ionis Pharmaceuticals Company Information
11.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Offered
11.8.3 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Ionis Pharmaceuticals Main Business Overview
11.8.5 Ionis Pharmaceuticals Latest Developments
11.9 Spark Therapeutics
11.9.1 Spark Therapeutics Company Information
11.9.2 Spark Therapeutics Viral Gene Therapy Product Offered
11.9.3 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spark Therapeutics Main Business Overview
11.9.5 Spark Therapeutics Latest Developments
11.10 Shanghai Sunway Biotech
11.10.1 Shanghai Sunway Biotech Company Information
11.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Offered
11.10.3 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Shanghai Sunway Biotech Main Business Overview
11.10.5 Shanghai Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Viral Gene Therapy Product Offered
11.11.3 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Viral Gene Therapy Product Offered
11.12.3 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Viral Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Viral Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Integrating Viral Vectors
Table 3. Major Players of Non-Integrating Viral Vectors
Table 4. Viral Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Viral Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Viral Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Viral Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Viral Gene Therapy Key Players Head office and Products Offered
Table 13. Viral Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Viral Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Viral Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Viral Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Viral Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Viral Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Viral Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Viral Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Viral Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Viral Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Viral Gene Therapy
Table 45. Key Market Challenges & Risks of Viral Gene Therapy
Table 46. Key Industry Trends of Viral Gene Therapy
Table 47. Global Viral Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Viral Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Viral Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Viral Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Lonza Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 52. Lonza Viral Gene Therapy Product Offered
Table 53. Lonza Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Lonza Main Business
Table 55. Lonza Latest Developments
Table 56. Biogen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 57. Biogen Viral Gene Therapy Product Offered
Table 58. Biogen Main Business
Table 59. Biogen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Biogen Latest Developments
Table 61. Catalent Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 62. Catalent Viral Gene Therapy Product Offered
Table 63. Catalent Main Business
Table 64. Catalent Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Catalent Latest Developments
Table 66. Gilead Sciences Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 67. Gilead Sciences Viral Gene Therapy Product Offered
Table 68. Gilead Sciences Main Business
Table 69. Gilead Sciences Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Gilead Sciences Latest Developments
Table 71. Sarepta Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 72. Sarepta Therapeutics Viral Gene Therapy Product Offered
Table 73. Sarepta Therapeutics Main Business
Table 74. Sarepta Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sarepta Therapeutics Latest Developments
Table 76. Novartis Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 77. Novartis Viral Gene Therapy Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Novartis Latest Developments
Table 81. Amgen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 82. Amgen Viral Gene Therapy Product Offered
Table 83. Amgen Main Business
Table 84. Amgen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Amgen Latest Developments
Table 86. Ionis Pharmaceuticals Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 87. Ionis Pharmaceuticals Viral Gene Therapy Product Offered
Table 88. Ionis Pharmaceuticals Main Business
Table 89. Ionis Pharmaceuticals Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Ionis Pharmaceuticals Latest Developments
Table 91. Spark Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 92. Spark Therapeutics Viral Gene Therapy Product Offered
Table 93. Spark Therapeutics Main Business
Table 94. Spark Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Spark Therapeutics Latest Developments
Table 96. Shanghai Sunway Biotech Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 97. Shanghai Sunway Biotech Viral Gene Therapy Product Offered
Table 98. Shanghai Sunway Biotech Main Business
Table 99. Shanghai Sunway Biotech Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Shanghai Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Viral Gene Therapy Product Offered
Table 103. SIBIONO Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 107. AnGes Viral Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Viral Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 1. Viral Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Integrating Viral Vectors
Table 3. Major Players of Non-Integrating Viral Vectors
Table 4. Viral Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Viral Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Viral Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Viral Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Viral Gene Therapy Key Players Head office and Products Offered
Table 13. Viral Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Viral Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Viral Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Viral Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Viral Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Viral Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Viral Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Viral Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Viral Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Viral Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Viral Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Viral Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Viral Gene Therapy
Table 45. Key Market Challenges & Risks of Viral Gene Therapy
Table 46. Key Industry Trends of Viral Gene Therapy
Table 47. Global Viral Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Viral Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Viral Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Viral Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Lonza Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 52. Lonza Viral Gene Therapy Product Offered
Table 53. Lonza Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Lonza Main Business
Table 55. Lonza Latest Developments
Table 56. Biogen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 57. Biogen Viral Gene Therapy Product Offered
Table 58. Biogen Main Business
Table 59. Biogen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Biogen Latest Developments
Table 61. Catalent Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 62. Catalent Viral Gene Therapy Product Offered
Table 63. Catalent Main Business
Table 64. Catalent Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Catalent Latest Developments
Table 66. Gilead Sciences Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 67. Gilead Sciences Viral Gene Therapy Product Offered
Table 68. Gilead Sciences Main Business
Table 69. Gilead Sciences Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Gilead Sciences Latest Developments
Table 71. Sarepta Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 72. Sarepta Therapeutics Viral Gene Therapy Product Offered
Table 73. Sarepta Therapeutics Main Business
Table 74. Sarepta Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Sarepta Therapeutics Latest Developments
Table 76. Novartis Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 77. Novartis Viral Gene Therapy Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Novartis Latest Developments
Table 81. Amgen Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 82. Amgen Viral Gene Therapy Product Offered
Table 83. Amgen Main Business
Table 84. Amgen Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Amgen Latest Developments
Table 86. Ionis Pharmaceuticals Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 87. Ionis Pharmaceuticals Viral Gene Therapy Product Offered
Table 88. Ionis Pharmaceuticals Main Business
Table 89. Ionis Pharmaceuticals Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Ionis Pharmaceuticals Latest Developments
Table 91. Spark Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 92. Spark Therapeutics Viral Gene Therapy Product Offered
Table 93. Spark Therapeutics Main Business
Table 94. Spark Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Spark Therapeutics Latest Developments
Table 96. Shanghai Sunway Biotech Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 97. Shanghai Sunway Biotech Viral Gene Therapy Product Offered
Table 98. Shanghai Sunway Biotech Main Business
Table 99. Shanghai Sunway Biotech Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Shanghai Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Viral Gene Therapy Product Offered
Table 103. SIBIONO Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 107. AnGes Viral Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Viral Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Viral Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Viral Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Viral Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Viral Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Viral Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Viral Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Viral Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Viral Gene Therapy in Metabolic Diseases
Figure 11. Global Viral Gene Therapy Market: Metabolic Diseases (2018-2023) & ($ Millions)
Figure 12. Viral Gene Therapy in Cardiovascular Diseases
Figure 13. Global Viral Gene Therapy Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Viral Gene Therapy in Muscular Diseases
Figure 15. Global Viral Gene Therapy Market: Muscular Diseases (2018-2023) & ($ Millions)
Figure 16. Viral Gene Therapy in Hematologic Diseases
Figure 17. Global Viral Gene Therapy Market: Hematologic Diseases (2018-2023) & ($ Millions)
Figure 18. Viral Gene Therapy in Ophthalmologic Diseases
Figure 19. Global Viral Gene Therapy Market: Ophthalmologic Diseases (2018-2023) & ($ Millions)
Figure 20. Viral Gene Therapy in Infectious Diseases
Figure 21. Global Viral Gene Therapy Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 22. Viral Gene Therapy in Others
Figure 23. Global Viral Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 24. Global Viral Gene Therapy Market Size Market Share by Application in 2022
Figure 25. Global Viral Gene Therapy Revenue Market Share by Player in 2022
Figure 26. Global Viral Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 27. Americas Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 28. APAC Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 29. Europe Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 30. Middle East & Africa Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 31. Americas Viral Gene Therapy Value Market Share by Country in 2022
Figure 32. United States Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Canada Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Mexico Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Brazil Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. APAC Viral Gene Therapy Market Size Market Share by Region in 2022
Figure 37. APAC Viral Gene Therapy Market Size Market Share by Type in 2022
Figure 38. APAC Viral Gene Therapy Market Size Market Share by Application in 2022
Figure 39. China Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Japan Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Korea Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Southeast Asia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. India Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Australia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Europe Viral Gene Therapy Market Size Market Share by Country in 2022
Figure 46. Europe Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Europe Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Germany Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. France Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. UK Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Italy Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Russia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 54. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 55. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 56. Egypt Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. South Africa Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 58. Israel Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 59. Turkey Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 60. GCC Country Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 61. Americas Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. APAC Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Europe Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Middle East & Africa Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. United States Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Canada Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Mexico Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Brazil Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. China Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Japan Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Korea Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Southeast Asia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. India Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Australia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Germany Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. France Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. UK Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Italy Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Russia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Spain Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 81. Egypt Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 82. South Africa Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 83. Israel Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 84. Turkey Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 85. GCC Countries Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 86. Global Viral Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 87. Global Viral Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Viral Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Viral Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Viral Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Viral Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Viral Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Viral Gene Therapy in Metabolic Diseases
Figure 11. Global Viral Gene Therapy Market: Metabolic Diseases (2018-2023) & ($ Millions)
Figure 12. Viral Gene Therapy in Cardiovascular Diseases
Figure 13. Global Viral Gene Therapy Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Viral Gene Therapy in Muscular Diseases
Figure 15. Global Viral Gene Therapy Market: Muscular Diseases (2018-2023) & ($ Millions)
Figure 16. Viral Gene Therapy in Hematologic Diseases
Figure 17. Global Viral Gene Therapy Market: Hematologic Diseases (2018-2023) & ($ Millions)
Figure 18. Viral Gene Therapy in Ophthalmologic Diseases
Figure 19. Global Viral Gene Therapy Market: Ophthalmologic Diseases (2018-2023) & ($ Millions)
Figure 20. Viral Gene Therapy in Infectious Diseases
Figure 21. Global Viral Gene Therapy Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 22. Viral Gene Therapy in Others
Figure 23. Global Viral Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 24. Global Viral Gene Therapy Market Size Market Share by Application in 2022
Figure 25. Global Viral Gene Therapy Revenue Market Share by Player in 2022
Figure 26. Global Viral Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 27. Americas Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 28. APAC Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 29. Europe Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 30. Middle East & Africa Viral Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 31. Americas Viral Gene Therapy Value Market Share by Country in 2022
Figure 32. United States Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Canada Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Mexico Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Brazil Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. APAC Viral Gene Therapy Market Size Market Share by Region in 2022
Figure 37. APAC Viral Gene Therapy Market Size Market Share by Type in 2022
Figure 38. APAC Viral Gene Therapy Market Size Market Share by Application in 2022
Figure 39. China Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Japan Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Korea Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Southeast Asia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. India Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Australia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Europe Viral Gene Therapy Market Size Market Share by Country in 2022
Figure 46. Europe Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Europe Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Germany Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. France Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. UK Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Italy Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Russia Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Middle East & Africa Viral Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 54. Middle East & Africa Viral Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 55. Middle East & Africa Viral Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 56. Egypt Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. South Africa Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 58. Israel Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 59. Turkey Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 60. GCC Country Viral Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 61. Americas Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. APAC Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Europe Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Middle East & Africa Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. United States Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Canada Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Mexico Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Brazil Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. China Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Japan Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Korea Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Southeast Asia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. India Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Australia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Germany Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. France Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. UK Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Italy Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Russia Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Spain Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 81. Egypt Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 82. South Africa Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 83. Israel Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 84. Turkey Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 85. GCC Countries Viral Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 86. Global Viral Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 87. Global Viral Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
